2024-05-08 01:28:55
AstraZeneca announced on Tuesday that it had started withdrawing its Covid-19 vaccine from around the world due to a “surplus of updated vaccines available” since the start of the pandemic.
The company also said it would begin withdrawing marketing licenses for the vaccine.Vaxifria” In Europe.
The company added: “With the development of multiple and variable vaccines For Covid-19 Since then, there has been a surplus of updated vaccines available,” she said, noting that this has led to a drop in demand for Vaxifria, which it no longer manufactures or supplies.
According to media reports, the British-Swedish pharmaceutical company previously admitted in court documents that the vaccine caused side effects such as blood clots and low platelet counts.
The company submitted a request to withdraw the vaccine on March 5, and it took effect on Tuesday, according to the Telegraph newspaper, which was first to report the developments.
And it started AstraZeneca The London-listed company pivoted to other vaccines and obesity drugs in several deals last year after growth slowed due to falling sales of Covid-19 treatments .
The Telegraph newspaper quoted AstraZeneca’s statement as saying:
• We are very proud of the role played by Vaxifria in ending… The epidemic Global.
• According to independent estimates, more than 6.5 million lives were saved in the first year of use. the vaccine Only more than three billion doses have been supplied worldwide.
• Our efforts have been recognized by governments around the world and are widely seen as a critical part of ending the global pandemic.
• We will work with regulatory authorities around the world to initiate the process of withdrawing the marketing authorization for Vaxifria, as no future commercial demand for the vaccine is anticipated.
1715174995
#AstraZeneca #withdraws #antiCorona #vaccine #worldwide